Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...

With insulin analogs, the currently dominant category, the most striking factor is that nearly 90% of the insulin analogs that have been completely discontinued in the U.S. remain available in Europe.

"Technosphere insulin has a unique delivery method, bioavailability, and pharmacodynamics leading to a very different clinical effect per unit compared to rapid-acting analogs." ...

Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma. It also casts ...

Collaboration and licensing agreements allowed additional companies to supply insulin. Innovations followed, such as increasing purity to improve tolerance, using microbes for production, and creating ...

Long-Acting Insulin Analogs Dominate the Global Biosimilar Market, While Rapid-Acting Insulins Lead in Growth Potential Global Insulin Biosimilar Market Global Insulin Biosimilar Market Dublin ...

Merilog is a rapid-acting human insulin analog designed to reduce spikes in blood sugar levels that typically occur during ...

Though it is more difficult to use than the newer rapid-acting analogs, regular insulin could be a useful option for those without health insurance or without access to their normal supplies.

Insulin analogs, which are synthetic versions of insulin, control blood sugar better than so-called human insulin, and represent more than 90% of the market, ...